361 Managed Futures Strategy Receives Top Morningstar

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
361 Managed Futures Strategy Receives Top Morningstar Rating

DENVER, June 11, 2015 (GLOBE NEWSWIRE) -- 361 Capital, a leading liquid alternative investments firm delivering institutional quality mutual funds, today announced its flagship 361 Managed Futures Strategy Fund (I Share Class), received a five-star Overall Morningstar Rating TM as of May 31, 2015, among 91 funds in the managed futures category.

The Fund's distinct counter-trend strategy follows a model designed to perform in volatile markets, regardless of direction, by taking advantage of market noise. 361 Managed Futures Strategy Fund is one of only two counter-trend strategies in the managed futures category, the other being the 361 Global Managed Futures Strategy Fund.

"The five-star accolade from Morningstar is a validation of our investment process and the 361 Managed Futures' counter-trend strategy," said Tom Florence, President and Chief Executive Officer of 361 Capital. "Its contrarian strategy goes against the herd – identifying when fear and greed are present in the market and profiting from these emotions. This unique approach has allowed for consistent achievement of superior risk-adjusted returns in volatile markets for our clients."

361 Managed Futures Strategy's high conviction model invests in the market during time periods where a return prospect outweighs risk. The strategy has a 100 percent hit ratio on all seven trades so far this year, and the highest three-year Sharpe Ratio and the smallest drawdown for its category for the three-year period ending May 31, 2015.

For more information about the 361 Managed Futures Strategy Fund or questions about implementing to alternative investment products, contact 866-361-1720.

Below is a chart with 361 Managed Futures Strategy Fund's performance.

 
Total Returns 1 month 3 months YTD 1 year 3 year Since Inception
(annualized for periods over 1 year)           12/20/2011
361 Managed Futures Strategy Fund 3.17% 4.42% 7.78% 11.07% 7.44% 7.48%
Morningstar Managed Futures Category 0.19% -1.09% 2.65% 13.25% 1.63% 0.81%
Returns as of 5/31/15            
As of 3/31/15, the 361 Managed Futures Strategy Fund returned 5.42% for the one year period and 6.55% since inception.
Annual Expense Ratio: Gross 1.90% / Net 1.90%†

The performance data quoted here represents past performance. Past performance is no guarantee of future results. Investment return and principal value will fluctuate, so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance information quoted. To obtain performance information current to the most recent month-end, please call 1-888-736-1227.

† Net ratio reflects contractual agreement in effect until February 28, 2016 under which the Fund's adviser waives certain fees or reimburse certain Fund expenses.

About 361 Capital

361 Capital is a liquid alternative investments firm focused on providing institutional quality mutual funds to investment advisors and their clients. Since its founding in 2001, the firm has been exclusively focused on alternative investments, creating innovative portfolio solutions that seek to lower risk, enhance returns, and provide transparency. This experience has provided 361 Capital with a deep understanding of the strategies that make up alternative investing, including long/short equity, managed futures, global macro, and multi-alternative. Today, the firm combines its investment skills and experience with that of other high quality alternative investment managers to offer a family of single-manager alternative mutual funds. 361 Capital's goal is to provide its clients with the highest quality mutual funds, whether managed by 361 Capital, or sub-advised by another proven alternative investment firm. The firm distributes its products through investment advisors and institutions. For more information, call 866-361-1720 or visit  www.361capital.com .

* Hit Ratio is the number of winning active signals divided by the number of total active signals. Sharpe ratio measures excess risk. The greater a portfolio's Sharpe ratio, the better its risk-adjusted performance has been. A negative Sharpe ratio indicates that a risk-less asset would perform better than the security being analyzed. Drawdown is the percentage drop in the price of an investment from its last peak price. The maximum drawdown measures the largest single drop from peak to bottom in the value of a portfolio (before a new peak is achieved). The lowest drawdown measures the smallest single drop from peak to bottom in the value of a portfolio (before a new peak is achieved).

About Morningstar Ratings

For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating™ based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a fund's monthly performance (including the effects of sales charges, loads, and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. The Overall Morningstar Rating™ for a fund is derived from a weighted average of the performance figures associated with its 3-, 5- and 10-year (if applicable) Morningstar Rating metrics. The 361 Managed Futures Strategy Fund was rated against the following numbers of U.S.-domiciled Managed Futures Funds over the following time period: 91 funds in the last three years. With respect to these Managed Futures category, the 361 Managed Futures Strategy Fund received a Morningstar Rating of five stars for the three-year period. Past performance is no guarantee of future results. Morningstar Rating is for the Class I Shares only; other classes may have different performance characteristics.

© 2015 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Investors should consider the 361 Funds' investment objectives, risks, charges and expenses carefully before investing. For a prospectus, or summary prospectus, that contains this and other information about the Funds, call 1-888-736-1227 or visit www.361capital.com . Please read the prospectus or summary prospectus carefully before investing.

Past performance does not guarantee future results. The Funds' performance may be influenced by political, social and economic factors affecting investments in foreign markets, including exposure to currency fluctuations relative to the U.S. dollar, less liquidity, less developed or less efficient trading markets, lack of comprehensive company information, political instability, and differing auditing and legal standards. Emerging markets tend to be more volatile than the markets of more mature economies. The value of securities held by the Funds may fall due to general market and economic conditions. The securities of small-cap companies may be subject to more abrupt or erratic market movements; trading may be more erratic or have lower volume than securities of larger companies. Fixed income securities are subject to the risk that securities could lose value because of interest rate, inflation and credit changes.

Derivatives can be highly volatile, illiquid and difficult to value, and changes in the value of a derivative held by the Funds may not correlate with the underlying instrument or the Funds' other investments. The Funds may make short sales, which may expose the Funds to the risk that it will be required to "cover" the short position at a time when the underlying instrument has appreciated in value, thus resulting in a loss to the Funds. Losses may be incurred even if they are "covered." The use of leverage may further magnify the Funds' gains or losses.

Funds' performance may be more vulnerable to changes in the market value of a single position and more susceptible to risks associated with a single economic, political or regulatory occurrence than a diversified fund. The Funds may have limited or no track record on which to base investment decisions. Regulators may undertake rulemaking, supervisory or enforcement actions that would adversely affect the Funds. Active and frequent trading may lead to a greater proportion of the Funds' gains being treated for federal income tax purposes as short-term capital gains or to distribute taxable income to its shareholders sooner than it would have distributed income if the investments were held for longer periods of time. Frequent trading and overlapping security transactions including ETFs would also result in transaction costs, which could detract from performance.

Alternative Investments are speculative and involve substantial risks. It is possible that investors may lose some or all of their investment.

The 361 Funds are distributed by IMST Distributors, LLC.

Taylor Smith (720) 726-5458

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 235

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 269

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 210

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 355

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 227

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 158

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Banyan Wins Inc. Power Partner Award for 3rd Year

Updated Category News Views 50

Red Banyan: A Powerhouse in B2B Support Red Banyan isn't just any player in the communications game; it's carved out a reputation as the go-to when businesses hit rough waters. You see, for the third consecutive year, this Fort Lauderdale-based firm bagged the Inc. Power Partner Award—a nod to its clout in the B2B arena. This accolade ain't about fancy ads; it's about...

Continue Reading
REA Group Pursues Rightmove Acquisition to Expand Globally

Updated Category News Views 85

REA Group's Bold Step into the UK Real Estate Market REA Group Ltd, a subsidiary of News Corporation, is stirring things up in the real estate sector with its recent proposal to acquire Rightmove plc, one of the UK's top real estate portals. This non-binding offer shows REA Group's ambitions to grow beyond Australia and tap into new international markets. Plans for...

Continue Reading
SiriusXM Announces Quarterly Dividend for Investors

Updated Category News Views 156

SiriusXM Announces Quarterly Cash Dividend SiriusXM (NASDAQ: SIRI) recently shared an important update with its shareholders. The Board of Directors has declared a quarterly cash dividend amounting to $0.27 per share of common stock. This significant step reflects the company’s ongoing commitment to providing value to its investors. Dividend Payment Details Stockholders...

Continue Reading
Market Update: IDX Composite Index Experiences Minor Decline

Updated Category News Views 200

Indonesia Stock Market: Daily Overview Trading on the Indonesian stock exchange finished a touch lower, with the IDX Composite Index slipping 0.06%. Losses in Infrastructure, Agriculture, and Basic Industry set the tone, and modest gains elsewhere weren’t enough to change the direction. It was a cautious, choppy session that underlined a still-challenging backdrop. Key...

Continue Reading
Innovative Snow and Ice Clearing Tool Revolutionizes Vehicle Care

Updated Category News Views 171

Revolutionary Ice Clearing Tool for Vehicles In the winter months, battling ice and snow on car windows can be a frustrating experience for many drivers. Recognizing this challenge, an inventive mind has come up with a solution that promises to change the way we deal with this common problem. The new design, known as the ICE SCRAPER, has been developed to enhance the...

Continue Reading